ESR1 and breast carcinoma: While TAM is a well-known selective estrogen receptor modulator used for breast cancer therapy for its antiestrogenic properties (48, 49), it is also a lysosomotropic compound that directly increases endolysosomal pH by acting as a weak base (45, 46, 47).